Patents by Inventor Aubrey Jones

Aubrey Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220071827
    Abstract: Systems and methods for providing data continuity for a mobile medical cart are provided. A battery board comprising a voltage detection circuit (“VCD”), a microcontroller, and a switching device electrically interposed between an alternative power source, a removable battery, and system boards for controlling cart functions. The microcontroller commands the switching device to: begin sourcing power solely from the alternative power source upon detection of a voltage decrease, begin sourcing power solely from the removable battery upon detection of a voltage increase where a valid charge state exists, and continue sourcing power solely from the alternative power source upon detection of the voltage increase where no valid charge state exists.
    Type: Application
    Filed: December 7, 2020
    Publication date: March 10, 2022
    Inventors: Justin Phillips, John St. Pierre, Aubrey Jones
  • Publication number: 20210319514
    Abstract: A combinatorial computer-based information system (CBIS) and computer-implemented method in consumer financial services and marketing strategies for providers and consumers using data science(s) and reciprocate Socratic teaching and learning communication methodologies is disclosed. The system and method create a digital pathway to inclusion, accelerating branding and national distribution channels.
    Type: Application
    Filed: April 8, 2021
    Publication date: October 14, 2021
    Inventor: Aubrey Jones
  • Patent number: 11053489
    Abstract: The present invention relates to cellobiohydrolase variants, polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of producing and using the variants.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: July 6, 2021
    Assignee: NOVOZYMES A/S
    Inventors: Mark Wogulis, Leslie Demars, Aubrey Jones, Hanshu Ding, David Osborn
  • Publication number: 20200325463
    Abstract: The present invention relates to cellobiohydrolase variants, polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of producing and using the variants.
    Type: Application
    Filed: June 30, 2020
    Publication date: October 15, 2020
    Applicant: Novozymes A/S
    Inventors: Mark Wogulis, Leslie Demars, Aubrey Jones, Hanshu Ding, David Osborn
  • Patent number: 10738293
    Abstract: The present invention relates to cellobiohydrolase variants, polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of producing and using the variants.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: August 11, 2020
    Assignee: Novozymes A/S
    Inventors: Mark Wogulis, Leslie Demars, Aubrey Jones, Hanshu Ding, David Osborn
  • Patent number: 10604967
    Abstract: A rectangular shaped lockable bin is defined by four walls and a bottom wall. A lid is hingedly mounted to the rear wall and has a slot located in a front portion thereof. A lock having a latch is pivotably mounted to the front wall of said bin at a pivot point and is configured to be selectively rotated between a locked position and an unlocked position by an actuator. A tail extending from the lock contacts a post located on the wall of the bin and basis the lock in the unlocked position. A series of such bins may be received in a delivery module, which may be received in a drawer.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: March 31, 2020
    Assignee: Capsa Solutions LLC
    Inventors: Maro Sciacchitano, Aubrey Jones, Justin Phillips, Christine Laliberte, Rody Hardy
  • Publication number: 20190085309
    Abstract: The present invention relates to cellobiohydrolase variants, polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of producing and using the variants.
    Type: Application
    Filed: March 2, 2017
    Publication date: March 21, 2019
    Applicant: Novozymes A/S
    Inventors: Mark Wogulis, Leslie Demars, Aubrey Jones, Hanshu Ding, David Osborn
  • Patent number: 10045899
    Abstract: The exemplary embodiments herein provide a medical cart having a drawer with a post which extends upwardly from a bottom surface of the drawer. The cart further includes a removable medication delivery module having four sidewalls and a bottom wall as well as a plurality of individually-lockable bins placed above the bottom wall and within the four sidewalls. A lock may be positioned above the bottom wall and below the plurality of individually-lockable bins with an aperture on the lock which engages with the post and a hole in the bottom wall sized to accept the post.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: August 14, 2018
    Inventors: Maro Sciacchitano, Aubrey Jones, Chris Miller, Rody Hardy
  • Patent number: 10045900
    Abstract: The exemplary embodiments herein provide a method for controlling access to medications. The method preferably includes the step of electronically unlocking a lid for a single bin out of a plurality of bins within a delivery module at a first location, to accept a medication into the unlocked bin, where the rest of the bins in the same delivery module remain locked. The method should then engage a mechanical lock on the lid once it has been closed, maintain the bin in a locked state during transport to a second location, and engage a mechanical lock on the delivery module once it has been lowered into a drawer at the second location.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: August 14, 2018
    Inventors: Maro Sciacchitano, Aubrey Jones, Chris Miller, Rody Hardy, Ken Guernsey
  • Publication number: 20180010366
    Abstract: A rectangular shaped lockable bin is defined by four walls and a bottom wall. A lid is hingedly mounted to the rear wall and has a slot located in a front portion thereof. A lock having a latch is pivotably mounted to the front wall of said bin at a pivot point and is configured to be selectively rotated between a locked position and an unlocked position by an actuator. A tail extending from the lock contacts a post located on the wall of the bin and basis the lock in the unlocked position. A series of such bins may be received in a delivery module, which may be received in a drawer.
    Type: Application
    Filed: July 6, 2017
    Publication date: January 11, 2018
    Inventors: Maro Sciacchitano, Aubrey Jones, Justin Phillips, Christine LaLiberte, Rody Hardy
  • Publication number: 20180008498
    Abstract: The exemplary embodiments herein provide a method for controlling access to medications. The method preferably includes the step of electronically unlocking a lid for a single bin out of a plurality of bins within a delivery module at a first location, to accept a medication into the unlocked bin, where the rest of the bins in the same delivery module remain locked. The method should then engage a mechanical lock on the lid once it has been closed, maintain the bin in a locked state during transport to a second location, and engage a mechanical lock on the delivery module once it has been lowered into a drawer at the second location.
    Type: Application
    Filed: December 9, 2016
    Publication date: January 11, 2018
    Inventors: Maro Sciacchitano, Aubrey Jones, Chris Miller, Rody Hardy, Ken Guernsey
  • Publication number: 20180008497
    Abstract: The exemplary embodiments herein provide a medical cart having a drawer with a post which extends upwardly from a bottom surface of the drawer. The cart further includes a removable medication delivery module having four sidewalls and a bottom wall as well as a plurality of individually-lockable bins placed above the bottom wall and within the four sidewalls. A lock may be positioned above the bottom wall and below the plurality of individually-lockable bins with an aperture on the lock which engages with the post and a hole in the bottom wall sized to accept the post.
    Type: Application
    Filed: December 9, 2016
    Publication date: January 11, 2018
    Inventors: Maro Sciacchitano, Aubrey Jones, Chris Miller, Rody Hardy
  • Publication number: 20170369860
    Abstract: The present invention relates to endoglucanase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, expression vectors, and recombinant host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: January 6, 2016
    Publication date: December 28, 2017
    Applicant: Novozymes A/S
    Inventors: Robert Blazej, Charles Emrich, Nicholas Toriello, Hanshu Ding, David Osborn, Aubrey Jones
  • Publication number: 20170298333
    Abstract: The present invention relates to variants of a parent glycoside hydrolase, comprising a substitution at one or more positions corresponding to positions 21, 94, 157, 205, 206, 247, 337, 350, 373, 383, 438, 455, 467, and 486 of amino acids 1 to 513 of SEQ ID NO: 2, and optionally further comprising a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2 a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2, wherein the variants have glycoside hydrolase activity. The present invention also relates to nucleotide sequences encoding the variant glycoside hydrolases and to nucleic acid constructs, vectors, and host cells comprising the nucleotide sequences.
    Type: Application
    Filed: June 21, 2017
    Publication date: October 19, 2017
    Applicant: Novozymes Inc.
    Inventors: Sarah Teter, Connie Ward, Joel Cherry, Aubrey Jones, Paul Harris, Jung Yi
  • Patent number: 9701951
    Abstract: The present invention relates to variants of a parent glycoside hydrolase, comprising a substitution at one or more positions corresponding to positions 21, 94, 157, 205, 206, 247, 337, 350, 373, 383, 438, 455, 467, and 486 of amino acids 1 to 513 of SEQ ID NO: 2, and optionally further comprising a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2 a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2, wherein the variants have glycoside hydrolase activity. The present invention also relates to nucleotide sequences encoding the variant glycoside hydrolases and to nucleic acid constructs, vectors, and host cells comprising the nucleotide sequences.
    Type: Grant
    Filed: September 3, 2014
    Date of Patent: July 11, 2017
    Assignee: Novozymes, Inc.
    Inventors: Sarah Teter, Connie Ward, Joel Cherry, Aubrey Jones, Paul Harris, Jung Yi
  • Publication number: 20150056664
    Abstract: The present invention relates to variants of a parent glycoside hydrolase, comprising a substitution at one or more positions corresponding to positions 21, 94, 157, 205, 206, 247, 337, 350, 373, 383, 438, 455, 467, and 486 of amino acids 1 to 513 of SEQ ID NO: 2, and optionally further comprising a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2 a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2, wherein the variants have glycoside hydrolase activity. The present invention also relates to nucleotide sequences encoding the variant glycoside hydrolases and to nucleic acid constructs, vectors, and host cells comprising the nucleotide sequences.
    Type: Application
    Filed: September 3, 2014
    Publication date: February 26, 2015
    Inventors: Sarah Teter, Connie Ward, Joel Cherry, Aubrey Jones, Paul Harris, Jung Yi
  • Patent number: 8822175
    Abstract: The invention relates to a continuous water monitoring system, including components thereof, and a method relating thereto for continuously monitoring, in real-time, a water supply in order to detect contaminants therein. The system employs the use of a live culture of bioluminescent bacteria and suitable light detecting means.
    Type: Grant
    Filed: May 17, 2006
    Date of Patent: September 2, 2014
    Assignee: Cymtox Limited
    Inventors: Colin Gibson, Gerald Melville Aubrey Jones, Francisco Gomez, John Thomas Magee, David Tallis Pooley, William Ralph Craig Stewart
  • Publication number: 20140080182
    Abstract: The present invention relates to cellobiohydrolase variants and cellulose binding domain variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: March 30, 2012
    Publication date: March 20, 2014
    Applicant: Novozymes, Inc.
    Inventors: Aubrey Jones, Paul Harris, Tia Heu, Doreen Bohan
  • Patent number: 8383385
    Abstract: The present invention relates to variants of a parent glycoside hydrolase, comprising a substitution at one or more positions corresponding to positions 21, 94, 157, 205, 206, 247, 337, 350, 373, 383, 438, 455, 467, and 486 of amino acids 1 to 513 of SEQ ID NO: 2, and optionally further comprising a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2 a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2, wherein the variants have glycoside hydrolase activity. The present invention also relates to nucleotide sequences encoding the variant glycoside hydrolases and to nucleic acid constructs, vectors, and host cells comprising the nucleotide sequences.
    Type: Grant
    Filed: January 19, 2011
    Date of Patent: February 26, 2013
    Assignee: Novozymes, Inc.
    Inventors: Sarah Teter, Connie Ward, Joel Cherry, Aubrey Jones, Paul Harris, Jung Yi
  • Publication number: 20130014293
    Abstract: The present invention relates to variants of a parent xylanase. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: March 2, 2011
    Publication date: January 10, 2013
    Applicants: NOVOZYMES A/S, NOVOZYMES, INC.
    Inventors: Janine Lin, Jung Ye, Aubrey Jones, Suzanne Otani, Tia Heu, Pierre Cassland, Esben Friis